1 STATE OF OKLAHOMA
2 1st Session of the 60th Legislature (2025)
3 HOUSE BILL 1974 By: Williams
4
5
6 AS INTRODUCED
7 An Act relating to preventative diagnostic services;
providing for eligibility; directing what the program
8 will provide; providing who will administer the
program; providing for coverage; providing for
9 educational and public awareness of the program;
requiring an annual report to the Legislature;
10 providing for codification; and providing an
effective date.
11
12
13 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
14 SECTION 1. NEW LAW A new section of law to be codified
15 in the Oklahoma Statutes as Section 7150 of Title 63, unless there
16 is created a duplication in numbering, reads as follows:
17 A. The Medicare program shall provide preventative health
18 screenings, advanced diagnostic testing, and imaging services
19 annually, at no cost, to Medicare-eligible individuals in the State
20 of Oklahoma.
21 B. Covered diagnostic tests and services include, but are not
22 limited to:
23 1. Annual coverage of cardiovascular testing to include the
24 following:
Req. No. 10871 Page 1

1 a. LDL direct,
2 b. Apo A1,
3 c. Apo B,
4 d. Apo B: Apo A-1 ratio,
5 e. PLAC test,
6 f. Homocysteine,
7 g. Ox-LDL (oxidized low-density lipoprotein),
8 h. MPO (myeloperoxidase),
9 i. NT-proBNP (N-terminal pro b-type Natriuretic Peptide),
10 j. sdLDL (small dense low-density lipoprotein), and
11 k. Lp(a) (lipoprotein(a));
12 2. Annual coverage of diabetes testing to include the
13 following:
14 a. blood glucose,
15 b. HbA1c (hemoglobin A1c),
16 c. glycated serum proteins,
17 d. adiponectin,
18 e. ferritin,
19 f. beta cell function testing, and
20 g. insulin levels;
21 3. Annual coverage of endocrinology testing to include the
22 following:
23 a. ANA (antinuclear antibodies),
24 b. ENA (extractable nuclear antigens),
Req. No. 10871 Page 2

1 c. PF IgM (phospholipid IgM),
2 d. Anti-CCP3 IgG and IgA (anti-cyclic citrullinated
3 peptide),
4 e. T3, triiodothyronine,
5 f. T4, thyroxine,
6 g. free T3 and free T4,
7 h. TSH (thyroid-stimulating hormone),
8 i. anti-TPO (thyroid peroxidase antibodies),
9 j. reverse T3, and
10 k. anti-TG (thyroglobulin antibodies); and
11 4. Coverage when warranted of advanced imaging to include
12 magnetic resonance imaging (MRI), for comprehensive cardiovascular,
13 neurological, and endocrinological assessments.
14 C. The State Department of Health shall administer the program
15 in collaboration with health care providers, laboratories, and
16 imaging facilities statewide.
17 D. Health care providers shall ensure that diagnostic services
18 are timely, accurate, and accessible to all eligible participants.
19 E. Each Medicare-eligible individual shall have the option to
20 access these preventative services annually if determined necessary
21 by his or her health care provider.
22 F. Additional diagnostic testing may be covered if medically
23 justified, ensuring comprehensive disease prevention.
24
Req. No. 10871 Page 3

1 G. No eligible individual shall incur out-of-pocket expenses
2 for any covered services.
3 H. The program shall include an educational campaign to inform
4 eligible individuals about the availability of preventative testing
5 and the importance of early detection.
6 I. Outreach efforts shall target communities statewide,
7 particularly rural and underserved areas.
8 J. 1. The Department shall submit an annual report to the
9 Oklahoma Legislature detailing:
10 a. the number of individuals served,
11 b. tests and services provided,
12 c. impact on early disease detection rates, and
13 d. cost savings achieved through preventative measures.
14 2. The report shall include recommendations for expanding or
15 improving the program.
16 SECTION 2. This act shall become effective November 1, 2025.
17
18 60-1-10871 TJ 01/05/25
19
20
21
22
23
24
Req. No. 10871 Page 4

[DELETED:  P Bgt]
[DELETED:  P L A A A P H O M N s L b H g a f b i A E]
[DELETED:  P P A T T f T a r a]
[DELETED:  P t t i c T 0]